The main source of commercial chitosan is the extensive deacetylation of its parent polymer chitin. It is present in green algae, the cell walls or fungi and in the exoskeleton of crustaceans. A novel procedure for preparing chitosan from shrimp shells was developed. The procedure involves two 10-minutes bleaching steps with ethanol after the usual demineralization and deproteinization processes. Before deacetylation, chitin was immersed in 12.5 M NaOH, cooled down and kept frozen for 24 h. The obtained chitosan was characterized using scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), UV, X-ray diffraction (XRD) and viscosimetry. Samples of white chitosan with acetylation degrees below were obtained, as determined by FTIR and UV-first derivative spectroscopy. The change in the morphology of samples was followed by SEM. The ash content of chitosan samples were all below . Chitosan was soluble in acetic acid with insoluble contents of or less. XRD patterns exhibited the characteristic peaks of chitosan centered at 10 and 20 degrees in . The molecular weight of chitosan was between 2.3 and 2.8 g/mol. It is concluded that the procedure developed in the present work allowed obtaining chitosans with physical and chemical properties suitable for pharmaceutical applications.
In this study, a method is described to determine the monolayer loading capacity (MLC) of the drugs naproxen and ibuprofen, both having high recrystallization tendencies, in mesoporous silica (MS), a well known carrier that is able to stabilize the amorphous form of a drug. The stabilization has been suggested to be due to direct absorption of the drug molecules onto the MS surface, i.e. the drug monolayer. In addition, drug that is not in direct contact with MS surface can fill the pores up to its pore filling capacity (PFC) and is potentially stabilized by confinement due to the pore size being smaller than a crystal nuclei. For drugs with high recrystallization tendencies, any drug outside the pores crystallizes due to its poor physical stability. The drug monolayer does not contribute to the glass transition temperature (Tg ) in the DSC, however, the confined amorphous drug above MLC has a Tg and the heat capacity (ΔCp) over the Tg increases with an increasing fraction of confined amorphous drug. Hence, several drug loading values above the MLC were investigated towards the presence of a Tg and ΔCp using differential scanning calorimetry (DSC). A linear correlation between the amount of confined amorphous drug and its ΔCp was identified for the mixtures between the MLC and PFC. By subsequent extrapolation to zero ΔCp the experimental MLC could be determined. Using theoretical density functional theory (DFT) and ab initio Molecular Dynamics (AIMD), the binding energies for the monolayer suggested that the monolayer in fact is thermodynamically more favorable than the crystalline form, whereas the confined amorphous form is thermodynamically less favorable. Consequently, a physical stability study showed that the confined amorphous drugs above the MLC were thermodynamically unstable and consequently flowing out of the pores in order to crystallize, whereas the monolayer remained physically stable.
O uso de polissacarídeos biodegradáveis com capacidade de formação de gel para produção de grânulos não tem sido relatado na literatura associados a novos derivados 2-aminotiofênicos, que tem demostrado atividade biológica antifúngica seletiva. Dessa forma o objetivo desse estudo foi avaliar a formação de grânulos de alginato para veiculação do derivado tiofênico e Insumo Farmacêutico Ativo (IFA) 5CN06 por gelificação ionotrópica. Foi produzido uma emulsão de 5CN06 a 0,1%, uma solução de alginato de sódio 3% e uma solução de CaCl2 a 10%. Sob distintos volumes a emulsão e o alginato foram misturadas e sob gotejamento, na solução CaCl2, os grânulos foram formados. A alteração da proporção de polímero interfere nesse rendimento, sendo esse igual e acima de 79,50 % ± 0,03. Em meio ácido, pH 1,2, o grânulo não possui significativa taxa de intumescimento, após 180 min. Em meio pH 7,4 ele se dissolve devido a presença de Na+. Utilizando 10mL das misturas de emulsão que contém o fármaco e 10 mL de solução de alginato de sódio a 3%, obteve-se grânulos, com melhor eficiência de encapsulação (65,7%). A maior razão da mistura interferiu na capacidade de intumescimento e na estabilização térmica do IFA. Dessa forma, o estudo desse sistema foi promissor, a partir das condições experimentais, para o entendimento da formação dos grânulos para liberação do composto derivado tiofênico 5CN06, com ação antifúngica.